ALMI Invest, together with Första Entreprenörsfonden, has invested SEK 2 million (€218,000) in Sprint Bioscience, a drug development services company specialising in lead generation.
The company carries out commissioned research for the pharmaceutical industry, and is also working to develop its own lead compounds.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
Follow where the public and private R&I money is going and which collaborative opportunities you can pursue.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
